نتائج البحث

Barriers and enablers of adverse drug event reporting in South Africa: a cross-sectional survey of medicine users.

• Authors : Ncube, Nokukhanya¹ (AUTHOR); Lubbe, Martha S.¹ (AUTHOR); Steyn, Hanlie¹ (AUTHOR)

• Source: BMC Public Health. 9/25/2025, Vol. 25 Issue 1, p1-8. 8p.

تفاصيل العنوان

Factors affecting integration of an early warning system for antimalarial drug resistance within a routine surveillance system in a pre-elimination setting in Sub-Saharan Africa.

• Authors : Kagoro FM; Collaborating Centre for Optimising Antimalarial Therapy (CCOAT), Division of Clinical Pharmacology, Department of Medicine, University of Cape Town (UCT), Cape Town, South Africa.; Mahidol Oxford Tropical Medicine Research Unit (MORU), Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.

Subjects: Antimalarials*/Antimalarials*/Antimalarials*/therapeutic use ; Antimalarials*/Antimalarials*/Antimalarials*/pharmacology ; Drug Resistance*/Drug Resistance*/Drug Resistance*/genetics

• Source: PloS one [PLoS One] 2025 Jun 03; Vol. 20 (6), pp. e0305885. Date of Electronic Publication: 2025 Jun 03 (Print Publication: 2025).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان

Treatment outcomes of short-regimen multi-drug resistant tuberculosis in uMkhanyakude district (2018-2022) South Africa: a retrospective, cross-sectional study.

• Authors : Mtolo L; Discipline of Public Health Medicine, University of KwaZulu-Natal, Durban, South Africa. .; Africa Health Research Institute, KwaZulu-Natal, Mtubatuba, South Africa. .

Subjects: Tuberculosis, Multidrug-Resistant*/Tuberculosis, Multidrug-Resistant*/Tuberculosis, Multidrug-Resistant*/drug therapy ; Tuberculosis, Multidrug-Resistant*/Tuberculosis, Multidrug-Resistant*/Tuberculosis, Multidrug-Resistant*/epidemiology ; Antitubercular Agents*/Antitubercular Agents*/Antitubercular Agents*/therapeutic use

• Source: BMC infectious diseases [BMC Infect Dis] 2025 Oct 21; Vol. 25 (1), pp. 1376. Date of Electronic Publication: 2025 Oct 21.Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334

تفاصيل العنوان

Acceptability of Digital Adherence Technologies to support people with drug-susceptible TB in South Africa.

• Authors : Dube TN; The Aurum Institute, Johannesburg South Africa.; Mboniswa F

Subjects: Tuberculosis*/Tuberculosis*/Tuberculosis*/drug therapy ; Tuberculosis*/Tuberculosis*/Tuberculosis*/epidemiology ; Medication Adherence*

• Source: PloS one [PLoS One] 2025 Sep 24; Vol. 20 (9), pp. e0332103. Date of Electronic Publication: 2025 Sep 24 (Print Publication: 2025).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان

A cross-sectional study evaluating the frequency of HIV drug resistance mutations among individuals diagnosed with HIV-1 in tenofovir disoproxil fumarate-based pre-exposure prophylaxis rollout programmes in Kenya, Zimbabwe, Eswatini and South Africa.

• Authors : Parikh UM; Kudrick LD ...

Subjects: HIV Infections*/HIV Infections*/HIV Infections*/virology ; HIV Infections*/HIV Infections*/HIV Infections*/prevention & control ; HIV Infections*/HIV Infections*/HIV Infections*/drug therapy

• Source: Journal of the International AIDS Society [J Int AIDS Soc] 2025 Aug; Vol. 28 (8), pp. e70011.Publisher: John Wiley & Sons, Inc Country of Publication: Switzerland NLM ID: 101478566 Publication Model: Print Cited Medium: Internet ISSN:

تفاصيل العنوان

Patient and provider costs of the new BPaL regimen for drug-resistant tuberculosis treatment in South Africa: A cost-effectiveness analysis.

• Authors : Evans D; Faculty of Health Sciences, Health Economics and Epidemiology Research Office, University of the Witwatersrand, Johannesburg, South Africa.; Hirasen K

Subjects: Tuberculosis, Multidrug-Resistant*/Tuberculosis, Multidrug-Resistant*/Tuberculosis, Multidrug-Resistant*/drug therapy ; Tuberculosis, Multidrug-Resistant*/Tuberculosis, Multidrug-Resistant*/Tuberculosis, Multidrug-Resistant*/economics ; Cost-Benefit Analysis*

• Source: PloS one [PLoS One] 2024 Oct 21; Vol. 19 (10), pp. e0309034. Date of Electronic Publication: 2024 Oct 21 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان

Genomic insights into Shigella species isolated from small ruminants and manure in the North West Province, South Africa.

• Authors : Motlhaping T; Unit for Environmental Sciences and Management, North-West University, Potchefstroom, 2520, South Africa.; Ramatla T

Subjects: Manure*/Manure*/Manure*/microbiology ; Genome, Bacterial* ; Shigella flexneri*/Shigella flexneri*/Shigella flexneri*/genetics

• Source: Applied microbiology and biotechnology [Appl Microbiol Biotechnol] 2025 Oct 28; Vol. 109 (1), pp. 238. Date of Electronic Publication: 2025 Oct 28.Publisher: Springer International Country of Publication: Germany NLM ID: 8406612 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

High rates of viral suppression in pregnancy drop postpartum in South African women on tenofovir-lamivudine-dolutegravir: a prospective cohort study.

• Authors : Abrams EJ; ICAP at Columbia University, Mailman School of Public Health, Columbia University, New York, New York, USA.; Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York, USA.

Subjects: HIV Infections*/HIV Infections*/HIV Infections*/drug therapy ; HIV Infections*/HIV Infections*/HIV Infections*/virology ; Tenofovir*/Tenofovir*/Tenofovir*/therapeutic use

• Source: Journal of the International AIDS Society [J Int AIDS Soc] 2025 Oct; Vol. 28 (10), pp. e70044.Publisher: John Wiley & Sons, Inc Country of Publication: Switzerland NLM ID: 101478566 Publication Model: Print Cited Medium: Internet ISSN:

تفاصيل العنوان

Ten-year outcomes of antiretroviral therapy: a retrospective cohort study in Tshwane district, South Africa.

• Authors : Mhlongo K; School of Health Systems and Public Health, University of Pretoria, Pretoria, South Africa.; Louw M

Subjects: HIV Infections*/HIV Infections*/HIV Infections*/drug therapy ; HIV Infections*/HIV Infections*/HIV Infections*/mortality ; HIV Infections*/HIV Infections*/HIV Infections*/epidemiology

• Source: AIDS research and therapy [AIDS Res Ther] 2025 Oct 21; Vol. 22 (1), pp. 108. Date of Electronic Publication: 2025 Oct 21.Publisher: BioMed Central Country of Publication: England NLM ID: 101237921 Publication Model: Electronic Cited Medium: Internet ISSN: 1742-6405

تفاصيل العنوان

Advancing HIV Drug Resistance Technologies and Strategies: Insights from South Africa's Experience and Future Directions for Resource-Limited Settings.

• Authors : Steegen, Kim^1,2,3 (AUTHOR) ; van Zyl, Gert U.^4,5 (AUTHOR) ; Claassen, Mathilda^4,5 (AUTHOR)

• Source: Diagnostics (2075-4418). Jul2023, Vol. 13 Issue 13, p2209. 11p.

تفاصيل العنوان